Tumor homing cells genetically engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

摘要

The invention refers to tumor-homing cells expressing the tumor necrosis factor-related apoptosis inducing ligand (TRIAL), particularly to CD34+ and NK cells transduced with adenoviral vectors coding for TRIAL. The cells of the invention are useful for the intravenous treatment of tumors, particularly of lymphoma.